Article Details
Retrieved on: 2024-12-27 02:00:34
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Learn more about Alto Neuroscience's ALTO-300, in ongoing phase 2b trials as an adjunct treatment for major depressive disorder.
Article found on: www.psychiatrictimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here